论文部分内容阅读
目的评价超声及血清125CA对于卵巢恶性肿瘤的诊断价值。方法分析经二维超声、彩色多普勒超声及血清125CA检查并经手术病理证实的卵巢癌患者109例。结果54例卵巢恶性肿瘤中,表现为囊性改变占9.5%;表现为囊实混合性为占64.6%;表现为实性改变占17.4%。超声检查及125CA在诊断卵巢恶性肿瘤上分别获得了90.8%、75.9%敏感度,96.4%、65.6%特异度,96.1%、68.3%阳性预测值,91.3%、73.5%阴性预测值,93.6%、71.6%准确度。超声检查比125CA具有更高的诊断价值,两者差异有统计学意义。联合使用可以提高敏感度和阴性预测值。结论超声诊断卵巢恶性肿瘤比125CA具有更高诊断价值;两者联合应用可以降低漏诊率,是筛查卵巢恶性肿瘤的良好办法。
Objective To evaluate the diagnostic value of ultrasonography and serum 125CA in malignant ovarian tumors. Methods 109 cases of ovarian cancer confirmed by two-dimensional ultrasonography, color Doppler ultrasound and serum 125CA and confirmed by surgery and pathology were analyzed. Results In 54 cases of ovarian malignant tumors, cystic changes accounted for 9.5%; cystic consolidation for the performance of 64.6%; showed a solid change accounted for 17.4%. Ultrasound and 125CA were 90.8%, 75.9%, 96.4%, 65.6% specificity, 96.1%, 68.3% positive predictive value, 91.3%, 73.5% negative predictive value, 93.6% 71.6% accuracy. Ultrasound has a higher diagnostic value than 125CA, the difference between the two is statistically significant. Combined use can increase the sensitivity and negative predictive value. Conclusion Ultrasound diagnosis of ovarian cancer has a higher diagnostic value than 125CA; the combination of the two can reduce the rate of missed diagnosis, which is a good way to screen ovarian cancer.